Hospital readmission for adult acute sickle cell painful episodes: Frequency, etiology, and prognostic significance

American Journal of Hematology

Volumn 79, Issue 1, 2005, Pages 17-25

  Ballas, Samir K ^a,b   Lusardi, Margaret ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Cardeza Foundation   (United States)

Author keywords

Hospital readmission; Pain management; Sickle cell anemia; Sickle cell pain

Indexed keywords

ANTIBIOTIC AGENT; HYDROMORPHONE; INFUSION FLUID; MORPHINE SULFATE; OPIATE; PETHIDINE;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PAIN; PAIN ASSESSMENT; PATHOGENESIS; PATIENT CONTROLLED ANALGESIA; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SICKLE CELL ANEMIA; SICKLE CELL PAIN; WITHDRAWAL SYNDROME;

ADULT; ANEMIA, SICKLE CELL; FEMALE; HUMANS; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; PAIN; PAIN MEASUREMENT; PATIENT READMISSION; PROGNOSIS;

EID: 18044397307     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20336     Document Type: Article

References (27)

1. Olney RS. Preventing morbidity and mortality from sickle cell disease: a public health perspective. Am J Prev Med 1999;16:116-120.
2. Consensus Development Panel, NIH, Newborn Screening for Sickle Cell Disease and other Hemoglobinopathies. JAMA 1987;258:1205-1209.
3. Ballas SK, Park D, Wapner RJ. Neonatal screening for sickle cell disease in a metropolitan university hospital: efficacy and problems. J Med Screen 1994;1:229-232.
4. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol 1996;18:36-41.
5. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-1599.
6. Abramson JS, Baker CJ, Fisher MC, et al. American Academy of Pediatrics Committee on Infectious Diseases: Policy Statement: Recommendations for the prevention of pneumococcal infections, including the case of pneumococcal conjugate vaccine (Prevnar) pneumococcal polysaccharide vaccine, and antibiotics prophylaxis. Pediatrics 2000;106:362-366.
7. Embury SH, Hebbel RP, Mohandas N, Steinberg MR. Sickle cell disease. Basic principles and clinical practice. New York: Raven Press; 1994.
8. Ballas SK. Sickle cell pain. Progress in pain research and management. Vol 11. Seattle, WA: IASP Press; 1998.
9. rd edition. Oxford, England: Oxford University Press; 2001.
10. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality and sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1634-1644.
11. Houston-Yu P, Rana SR, Beyer B, Castro O. Frequent and prolonged hospitalization: a risk factor for early mortality in sickle cell disease patients. Am J Hematol 2003;72:201-203.
12. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
13. Woods K, Karrison T, Koshy M, Patel A, Friedman P, Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Publ Health Rep 1997;112:44-51.
14. Ballas SK. Bone marrow transplantation in sickle cell anemia: Why so few so late? Lancet 1992;340:1226.
15. Bain BJ. Hemoglobinopathy diagnosis. Oxford, England: Blackwell Science; 2001.
16. Fishman B, Pasternak S, Wallenstein SL, Houde RW, Holland JC, Foley KM. The Memorial Pain Assessment card: a valid instrument for the evaluation of cancer pain. Cancer 1987;60:1151-1158.
17. Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood 2000;95(4):1130-1136.
18. Carr DB, Jacox A, Chapman R, et al. Acute pain management: Operative or medical procedures and trauma. Clinical practice guideline. AHCPR publication no. 92-0032. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Services; 1992.
19. Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical practice guideline no. 9. AHCPR Publication No. 94-0592. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Services; 1994.
20. Ballas SK, Delengowski A. Pain measurement in hospitalized adults with sickle cell painful episodes. Ann Clin Lab Sci 1993;23:358-361.
21. Wilkinson L. Systat: the system for statistics. Evanston, IL: Systat, Inc.; 1986.
22. Benjamin LJ, Dampier CD, Jacox A, et al. Guideline for the management of acute and chronic pain in sickle cell disease. Clinical practice guideline no 1. Glenview, IL: American Pain Society; 1999.
23. University Health System Consortium, Clinical Database. Chicago, IL, 2004, date of access August 26, 2004.
24. Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain 2003;102:187-193.
25. van Walraven C, Mamdani M, Fang J, Austin PC. Continuity of care and patient outcomes after hospital discharge. J Gen Intern Med 2004;19:624-631.
26. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003;138:161-167.
27. Udezue E, Girshab AM. Differences between males and females in adult sickle cell pain crisis in Eastern Saudi Arabia. Ann Saudi Med 2004;24:179-182.